INTERNATIONAL WEX TECH INC

[Marketwire] - VANCOUVER, BRITISH COLUMBIA-- - WEX Pharmaceuticals Inc. announced today that WEX Research and Development staff and some participating clinical investigators will present a poster entitled "Long-Term Open-Label Study of Tetrodotoxin in Cancer Pain" at the 13th World Congress on Pain which will be held next week in Montreal, Canada.